COMMUNIQUÉS West-GlobeNewswire

Notice of Annual General Meeting in Immunicum AB (publ)
26/03/2019
Press Release 26 March 2019 Notice of Annual General Meeting in Immunicum AB (publ) The shareholders of Immunicum AB (publ) (the "Company"), reg. no 556629-1786, are hereby invited to the Annual General Meeting on [...]
Wildflower Brands Inc. (CSE : SUN) (OTCQB : WLDFF) en vedette dans la publication NetworkNewsWire sur l'industrie du CBD à base de chanvre en forte progression
26/03/2019
NEW YORK, 26 mars 2019 (GLOBE NEWSWIRE) -- via NetworkWire – NetworkNewsWire (« NNW »), société d’information financière et d’édition à multiples facettes, annonce aujourd’hui la publication d’un éditorial présentant [...]
CFO of Oasmia, Anders Blom has resigned
26/03/2019
Yesterday Oasmia received the resignation of the Company’s CFO Anders Blom. The Board and the CEO have decided to appoint, as acting CFO, Joakim Lindén. Joakim Lindén has long experience from transition processes in [...]
Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero
26/03/2019
Menarini Diagnostics to distribute Unyvero Platform and application cartridges in numerous European countries Menarini Diagnostics to deploy its commercial team for the marketing of Unyvero Platform across Europe [...]
Verona Pharma to Present at H.C. Wainwright Global Life Sciences Conference
26/03/2019
LONDON, March 26, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (NASDAQ: VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedback
26/03/2019
Moving forward with Overall Survival (OS)-based, randomized, event-driven clinical trial for the United States Pre-IND feedback from US Food and Drug Administration (FDA) provides clarity to Nanobiotix on US regulatory [...]
Nanobiotix annonce son plan d’enregistrement clinique dans les cancers de la Tête et du Cou avec NBTXR3 aux Etats-Unis à la suite du retour de la FDA
26/03/2019
Préparation d’une étude clinique évènementielle, randomisée et évaluant la survie globale (SG) aux États-Unis Le retour (pre-IND) de la Food and Drug Administration (FDA) permet de clarifier l’approche réglementaire aux [...]
Tecan publishes 2018 Annual Report and notice of its Annual General Meeting
26/03/2019
Männedorf, Switzerland, March 26, 2019 - The Tecan Group (SIX Swiss Exchange: TECN) today announced the publication of its 2018 Annual Report in the Investor Relations section of the company's website at www.tecan.com [...]
Multidisciplinary Experts Leverage Global Action for Local Impact to Protect Communities at Risk of Typhoid and Related Diseases
26/03/2019
HANOI, Vietnam, March 25, 2019 (GLOBE NEWSWIRE) -- Beginning today, the 11 th International Conference on Typhoid and Other Invasive Salmonelloses brings together more than 450 researchers, policy makers and advocates [...]
Novel compound for treatment of traumatic brain injury (TBI) demonstrates positive results in a preclinical study
25/03/2019
Strongest announced preclinical results of any drug candidate currently in development for TBI Significant results in neurobehavior as measured by actigraphy. GRAFTON, Mass., March 25, 2019 (GLOBE NEWSWIRE) -- Ischemix [...]
RadNet, Inc. to Present at the Sidoti & Company Spring 2019 Conference on Thursday, March 28th
25/03/2019
LOS ANGELES, March 25, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
Precision Therapeutics Announces Results of Special Meeting of Stockholders
25/03/2019
MINNEAPOLIS, March 25, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (Nasdaq: AIPT) (the “Company”) announced today that at a special meeting of stockholders held on March 22, 2019, the Company’s stockholders [...]
Precision Therapeutics to Report Fiscal Year 2018 Financial Results and Provide Company Update on Monday, April 1, 2019
25/03/2019
Conference Call to be held April 1, 2019, at 4:30pm Eastern Time MINNEAPOLIS, March 25, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announces that it will [...]
Agritek Holdings Inc. Announces Reverse Stock Split in Preparation for Proposed Uplisting To National Markets And OTCQB
25/03/2019
LOS ANGELES, CA, March 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and brand licensor for [...]
PhaseBio Announces Term Loan of up to $15 Million
25/03/2019
Entered into term loan facility with Silicon Valley Bank and WestRiver Innovation Lending Fund to borrow up to $15 million Funds will be used to advance clinical development of PB2452, a reversal agent for ticagrelor, [...]
Kane Biotech Announces Fourth Quarter and Full Year 2018 Financial Results
25/03/2019
WINNIPEG, Manitoba, March 25, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
CytomX Therapeutics Announces Transition of Chief Financial Officer
25/03/2019
SOUTH SAN FRANCISCO, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
BriaCell Closes First Tranche of Previously Announced Non-Brokered Private Placement
25/03/2019
BERKELEY, Calif. and VANCOUVER, British Columbia, March 25, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
MRI Interventions Congratulates Dr. Clark Chen On First Patient Dosing In Minnesota For Phase 2 Glioblastoma Trial
25/03/2019
IRVINE, Calif., March 25, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company developing products designed for navigation, ablation, deep brain stimulation, biopsy, aspiration [...]

Pages